GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Accuray Inc (LTS:0H8I) » Definitions » Cyclically Adjusted FCF per Share

Accuray (LTS:0H8I) Cyclically Adjusted FCF per Share : $0.01 (As of Mar. 2025)


View and export this data going back to 2018. Start your Free Trial

What is Accuray Cyclically Adjusted FCF per Share?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

Accuray's adjusted free cash flow per share for the three months ended in Mar. 2025 was $0.152. Add all the adjusted free cash flow per share for the past 10 years together and divide the count will get our Cyclically Adjusted FCF per Share, which is $0.01 for the trailing ten years ended in Mar. 2025.

During the past 3 years, the average Cyclically Adjusted FCF Growth Rate was 50.00% per year. During the past 5 years, the average Cyclically Adjusted FCF Growth Rate was 38.10% per year. During the past 10 years, the average Cyclically Adjusted FCF Growth Rate was 19.50% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted FCF Growth Rate using Cyclically Adjusted FCF per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted FCF Growth Rate of Accuray was 50.00% per year. The lowest was 4.80% per year. And the median was 12.60% per year.

As of today (2025-05-30), Accuray's current stock price is $1.6394. Accuray's Cyclically Adjusted FCF per Share for the quarter that ended in Mar. 2025 was $0.01. Accuray's Cyclically Adjusted Price-to-FCF of today is 163.94.

During the past 13 years, the highest Cyclically Adjusted Price-to-FCF of Accuray was 232.95. The lowest was 136.50. And the median was 157.00.


Accuray Cyclically Adjusted FCF per Share Historical Data

The historical data trend for Accuray's Cyclically Adjusted FCF per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Accuray Cyclically Adjusted FCF per Share Chart

Accuray Annual Data
Trend Jun15 Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23 Jun24
Cyclically Adjusted FCF per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only -0.27 -0.25 -0.19 -0.04 -0.03

Accuray Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Cyclically Adjusted FCF per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.05 -0.03 -0.01 -0.01 0.01

Competitive Comparison of Accuray's Cyclically Adjusted FCF per Share

For the Medical Devices subindustry, Accuray's Cyclically Adjusted Price-to-FCF, along with its competitors' market caps and Cyclically Adjusted Price-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Accuray's Cyclically Adjusted Price-to-FCF Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Accuray's Cyclically Adjusted Price-to-FCF distribution charts can be found below:

* The bar in red indicates where Accuray's Cyclically Adjusted Price-to-FCF falls into.


;
;

Accuray Cyclically Adjusted FCF per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

What is Cyclically Adjusted FCF per Share? How do we calculate Cyclically Adjusted FCF per Share?

Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted FCF per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the free cash flow per share from 2001 through 2010.

We adjusted the 2001 free cash flow per share data with the total inflation from 2001 through 2010 to the equivalent free cash flow in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's free cash flow is $1 a share in 2001, then the 2001's equivalent free cash flow in 2010 is $1.4 a share. If Wal-Mart's free cash flow is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 free cash flow in 2010 is $1.35. So on and so forth, you get the equivalent free cash flow per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted FCF per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Accuray's adjusted Free Cash Flow per Share data for the three months ended in Mar. 2025 was:

Adj_FreeCashFlowPerShare= Free Cash Flow per Share /CPI of Mar. 2025 (Change)*Current CPI (Mar. 2025)
=0.152/134.9266*134.9266
=0.152

Current CPI (Mar. 2025) = 134.9266.

Accuray Quarterly Data

Free Cash Flow per Share CPI Adj_FreeCashFlowPerShare
201506 -0.080 100.684 -0.107
201509 0.134 100.392 0.180
201512 0.068 99.792 0.092
201603 -0.133 100.470 -0.179
201606 0.218 101.688 0.289
201609 -0.099 101.861 -0.131
201612 -0.074 101.863 -0.098
201703 -0.157 102.862 -0.206
201706 0.257 103.349 0.336
201709 -0.167 104.136 -0.216
201712 -0.021 104.011 -0.027
201803 0.018 105.290 0.023
201806 0.302 106.317 0.383
201809 -0.225 106.507 -0.285
201812 -0.165 105.998 -0.210
201903 -0.093 107.251 -0.117
201906 0.091 108.070 0.114
201909 -0.292 108.329 -0.364
201912 0.168 108.420 0.209
202003 -0.138 108.902 -0.171
202006 0.198 108.767 0.246
202009 -0.038 109.815 -0.047
202012 0.200 109.897 0.246
202103 0.168 111.754 0.203
202106 0.058 114.631 0.068
202109 -0.111 115.734 -0.129
202112 0.339 117.630 0.389
202203 -0.246 121.301 -0.274
202206 -0.065 125.017 -0.070
202209 -0.013 125.227 -0.014
202212 -0.207 125.222 -0.223
202303 0.234 127.348 0.248
202306 0.009 128.729 0.009
202309 -0.100 129.860 -0.104
202312 -0.065 129.419 -0.068
202403 -0.090 131.776 -0.092
202406 0.095 132.554 0.097
202409 -0.084 133.029 -0.085
202412 0.002 133.157 0.002
202503 0.152 134.927 0.152

Add all the adjusted free cash flow per share together and divide 10 will get our Cyclically Adjusted FCF per Share.


Accuray  (LTS:0H8I) Cyclically Adjusted FCF per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted FCF per Share may underestimate the company's free cash flow. Cyclically Adjusted Price-to-FCF can seem to be too high even the actual Price-to-Free-Cash-Flow is low.

For the Cyclically Adjusted Price-to-FCF, the free cash flow per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/FCF calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted Price-to-FCF is also called CAPFCF Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted free cash flow per share of a company over the past 10 years.

Accuray's Cyclically Adjusted Price-to-FCF of today is calculated as

Cyclically Adjusted Price-to-FCF=Share Price/Cyclically Adjusted FCF per Share
=1.6394/0.01
=163.94

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted Price-to-FCF of Accuray was 232.95. The lowest was 136.50. And the median was 157.00.


Be Aware

Cyclically Adjusted Price-to-FCF works better for cyclical companies. It gives you a better idea on the company's real free cash flow value.


Accuray Cyclically Adjusted FCF per Share Related Terms

Thank you for viewing the detailed overview of Accuray's Cyclically Adjusted FCF per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


Accuray Business Description

Traded in Other Exchanges
Address
1240 Deming Way, Madison, WI, USA, 53717
Accuray Inc is a radiation oncology company that develops, manufactures, sells and supports precise, innovative treatment solutions which set the standard of radiation therapy care with the aim of helping patients live better lives. The company's technology, The CyberKnife, is used to treat multiple types of cancer and tumors throughout the body. The CyberKnife Systems automatically track, detect and correct for a tumor and patient movement in real-time during the procedure, enabling delivery of precise, high dose radiation with sub-millimetre accuracy while patients breathe normally, without manual user intervention.

Accuray Headlines

No Headlines